preserving vision
Millions of lives are affected by diabetic retinopathy — a leading cause of preventable blindness. Recognizing the urgent need for early detection, Malaysia’s Ministry of Health, developed DR MATA in collaboration with Qmed Asia.
This innovative AI-powered solution is designed to detect diabetic retinopathy with unmatched speed, accuracy, and accessibility.
With DR. Mata, early detection becomes accessible, fast, and accurate, ensuring better outcomes for patients everywhere.
Install the DR MATA AI software on the PC connected to the fundus camera for seamless integration and operation.
The AI processes retinal images in real-time, delivering results within 30 seconds with 83% accuracy. It grades diabetic retinopathy as Grade 0, 1, or 2, providing doctors with quick and precise assessments.
Built-in with a Referral Module to Tertiary Centers and an integrated Ask CPG feature, it offers detailed referral pathways and instant access to Clinical Practice Guidelines to support efficient patient management.
Early Detection
Through AI-powered screening, DR.MATA identifies diabetic retinopathy at its earliest stages, preventing irreversible vision loss and improving long-term outcomes.
Improved Access
DR MATA seamlessly integrates with various fundus camera brands, enabling healthcare providers to adopt advanced eye care solutions effortlessly. Its scalable and affordable technology ensures high-quality screening is accessible to all, including underserved communities.
Better Outcomes
DR MATA includes an integrated Ask CPG feature and a Referral Module, providing clinicians with instant access to Clinical Practice Guidelines and detailed referral pathways. This ensures timely interventions, improved patient care, and better treatment outcomes.
Join us as we expand our AI solutions to tackle diabetic retinopathy and other eye diseases.